Editorial draft — not for publication yet. Methylphenidate content needs clinical and legal review before publication. This page is general information and is not advice about an individual prescription.
In short
General Pharmaceuticals Limited’s product information identifies Methyphen as a methylphenidate hydrochloride USP 10 mg tablet and lists ADHD and narcolepsy. This manufacturer information describes a Bangladesh product; it does not confirm the contents of an individual pack or establish UK authorisation. Methylphenidate is prescription-only and a Class B, Schedule 2 controlled drug in the UK. Do not use it without an appropriate prescription and clinical monitoring.
For the general active-ingredient guide, continue to Methylphenidate medicine guide. This page covers Methyphen-specific product questions.
Methyphen UK product status
The manufacturer lists Methyphen as methylphenidate hydrochloride tablets in Bangladesh. That product information does not establish UK authorisation or current UK supply for a particular Methyphen pack. Check the exact brand, manufacturer, strength and formulation in the MHRA Products database or with a UK pharmacist; a UK authorisation for another methylphenidate product does not automatically apply.
What is Methyphen listed for, and what does UK guidance say?
General Pharmaceuticals’ Bangladesh insert lists ADHD and narcolepsy for Methyphen (methylphenidate). NHS information also describes methylphenidate use for ADHD and sometimes narcolepsy, while NICE provides UK ADHD treatment guidance. These references do not establish that an overseas Methyphen pack is authorised or suitable for an individual in the UK.
- The manufacturer insert lists ADHD and narcolepsy for methylphenidate in its Bangladesh product information.
- NICE includes methylphenidate in specific UK ADHD treatment pathways after appropriate assessment and monitoring.
- A brand name and 10 mg tablet strength do not establish a personal dose, UK authorisation or interchangeability with another brand.
- Methyphen is not an anxiety medicine, insomnia treatment, study aid or general-purpose wakefulness medicine.
NICE recommends baseline assessment and follow-up for ADHD medicines, including review of medical history, current medicines, pulse, blood pressure, height and weight as appropriate.
Methylphenidate is prescription-only and listed as Class B, Schedule 2 in UK controlled-drug guidance. Ingredient status does not authenticate or establish UK authorisation of an individual Methyphen pack.
How does it work?
Methyphen’s stated active ingredient is methylphenidate hydrochloride, a central nervous system stimulant that affects dopamine and noradrenaline signalling involved in attention and behaviour. Its effects and duration depend on the person and the exact product and release formulation; a Bangladesh brand listing cannot establish an individual pack’s contents or equivalence to a UK product.
Risks and possible effects
Possible methylphenidate effects
Methylphenidate may cause headache, appetite changes, stomach discomfort, restlessness or sleep difficulty. It can also affect pulse, blood pressure or mood; check the exact leaflet.
Urgent warning signs
Call 999 for chest pain, seizure, collapse, severe allergic reaction, severe agitation or another life-threatening symptom. Contact NHS 111 urgently after taking more than prescribed.
Safety information
- A Bangladesh manufacturer insert does not establish that a specific Methyphen pack is authorised for UK supply. Verify the exact product with MHRA records or a UK pharmacist.
- Do not take methylphenidate unless it was prescribed for you and dispensed through appropriate safeguards. Do not share it or use it as a study aid.
- Tell the prescriber about heart or blood-pressure conditions, mental-health history, seizures, other medicines and supplements before treatment.
- NHS says methylphenidate must not be taken with an MAOI or within 14 days after stopping one; ask a pharmacist to check other interactions.
- Follow your exact product directions. Different methylphenidate brands and release types may not be interchangeable.
- Keep methylphenidate securely stored and away from children and other people.
Methyphen: brand name and generic ingredient
General Pharmaceuticals’ insert identifies Methyphen as methylphenidate hydrochloride USP and says each listed tablet contains 10 mg. Methyphen is the brand name; methylphenidate hydrochloride is the active ingredient.
This describes the manufacturer’s Bangladesh product information, not a chemical test of a particular tablet. The strength is not a personal dose instruction, and the source does not establish the contents of an unfamiliar pack.
UK status, prescription and controlled-drug checks
The Methyphen product information reviewed here is from a Bangladesh manufacturer. It does not establish UK authorisation or current supply of the exact branded product. Check the MHRA Products database or ask a UK pharmacist about the name, strength, formulation and manufacturer.
Methylphenidate is prescription-only and Class B, Schedule 2 in UK controlled-drug guidance. That ingredient-level status is different from authorisation of a specific product. Do not use Methyphen unless it was prescribed and supplied to you through appropriate safeguards.
ADHD and narcolepsy: product information and UK context
General Pharmaceuticals lists ADHD and narcolepsy in the Methyphen insert. NHS information describes methylphenidate for ADHD and sometimes narcolepsy. The exact indication, age range, product licence and treatment plan depend on the product and the person.
NICE recommends methylphenidate in defined ADHD pathways after assessment and with monitoring. A guideline recommendation for the generic ingredient does not authenticate an overseas brand or mean it is right for everyone.
Strength and release formulation matter
The manufacturer source identifies a 10 mg tablet, but this does not tell a person how much to take. Methylphenidate products may differ in formulation and release characteristics, so the full product name and dispensing label matter.
Do not copy a dose from an online insert, switch brands or convert between formulations yourself. Ask the prescriber or pharmacist to check the exact product and provide directions for you.
Not an anxiety medicine, sleep treatment or study aid
Methylphenidate is a stimulant for defined clinical uses, not a treatment for anxiety or insomnia and not a general study or performance aid. Sleep difficulty, appetite changes and other effects can occur.
If attention, sleepiness, anxiety or poor sleep is affecting daily life, seek appropriate assessment. Do not experiment with a controlled stimulant or use medicine prescribed to someone else.
Read the UK methylphenidate guide
The separate methylphenidate guide covers UK ADHD recommendations, narcolepsy, formulations, monitoring, side effects, interactions and controlled-drug status.
This Methyphen cluster focuses on the manufacturer’s Bangladesh product listing, how it differs from UK product records and brand-specific safety questions.
Frequently asked questions
What is Methyphen?
General Pharmaceuticals lists Methyphen as a methylphenidate hydrochloride tablet in Bangladesh. Its insert states a strength of 10 mg per tablet.
What is the generic name of Methyphen?
Methylphenidate hydrochloride is the active ingredient named in the manufacturer’s insert.
Is Methyphen available in the UK?
A Bangladesh product listing does not establish UK authorisation or current supply. Check the exact product in the MHRA database or with a UK pharmacist.
Can Methyphen be used for anxiety or studying?
No. Methylphenidate is not an anxiety treatment or study aid. Use it only when appropriately prescribed for a clinical indication.
Is Methyphen a controlled drug in the UK?
Methylphenidate is prescription-only and Class B, Schedule 2 in UK guidance. This does not verify an individual Methyphen pack.
Explore the detailed methyphen (methylphenidate) guides
Each guide answers a different practical question. Advice is specific to methylphenidate and should be checked against your own product leaflet and prescription.
- What is Methyphen? Methylphenidate brand information
- Methyphen generic name and 10 mg strength explained
- Is Methyphen available in the UK? Product status explained
- Methyphen uses: ADHD, narcolepsy and UK guidance
- Methyphen dosage and how to take it safely
- Methyphen side effects and interactions: methylphenidate safety
- Can Methyphen be used for anxiety, sleep or studying?
- Methyphen vs Ritalin and Alaradate: brand differences
- Methyphen product checks, prescription safety and storage
Sources and review
This draft was checked against the sources below on 3 October 2026. It still requires clinical and legal review before publication.
- General Pharmaceuticals Limited, Bangladesh: Methyphen: manufacturer product insert
- General Pharmaceuticals Limited, Bangladesh: Methyphen product listing
- NHS: About methylphenidate for adults
- NHS: How and when to take methylphenidate
- NHS: Methylphenidate side effects and urgent advice
- NHS: Methylphenidate interactions with medicines and supplements
- NHS: Who can and cannot take methylphenidate
- NICE: ADHD diagnosis, treatment and monitoring recommendations
- NHS Specialist Pharmacy Service: Prescribing and switching between modified-release methylphenidate products
- MHRA: Search UK medicine product records
- Home Office / GOV.UK: Controlled-drugs list and schedules
- GOV.UK: Drug possession and supply penalties
- NHS: Poisoning: what to do
Editorial status: Editorial draft — clinical and UK product-status review required before publication.